METTL3 and neoplasm: As depicted in Figure 4E, the mice bearing DLBCL cells with silenced expression of METTL3 displayed remarkably lower luminescence intensities than those in the control group, suggesting a METTL3 knockdown-induced inhibition in the tumor progression in vivo.